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VMAT treatments, and it is based on correlation functions 
between EPID signals and doses in patient. The software is 
easy to implement for Varian, Elekta and Siemens linacs, and 
it is connected with the Record and Verify system of the 
Center, supplying the results in a few seconds. The method 
supplies two tests (i) the ratio R=(Diso/Diso,TPS) between the 
reconstructed and computed isocentre dose, with pass 
criteria of ±5% and (ii) a 2D γ-analysis between EPID images 
with the following pass criteria: the percentage of the points 
Pγ<1 should be higher than 90% for 3DCRT and 95% for IMRT 
and VMAT; the γ-mean should be less than 0.5 and 0.3 for 
3DCRT and IMRT-VMAT respectively.  
 
Results: The percentage of the off-tolerance tests ranged 
between 10% and 17%, depending on the type of treatment 
checked. The causes of dosimetric discrepancies, in order of 
frequency were: setu-up variations, attenuators left in the 
field, morphological changes, TPS implementation and linac 
output factor. All the causes of the off-tolerance tests were 
justified and, once removed, the mean R values of all 
patients were within 5% and the γ-analysis indexes satisfied 
the specific pass criteria. The discrepancies due to patient 
morphological changes triggered new TC or CBCT scans to 
verify the need of an adaptive plane. Some of these cases 
have been discussed by radiotherapists and physicists. 
 
Conclusion: The multicenter result proved: (i) the great 
utility to obtain IVD tests in quasi real time, (ii) the positive 
role of the physicists during the dose-delivery step, (iii) 
SOFTDISO allows to understand the causes of dose 
discrepancies triggering adequate QC, and once the causes of 
errors were removed all the pass criteria were respected (iv) 
the role of IVD to intercept patient morphological changes to 
examine for eventual adaptive radiotherapy strategy. 
 
Proffered Papers: Physics 9: Adaptive RT for inter-fraction 
motion management  
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Purpose or Objective: To date no satisfactory treatment 
options exist for locally advanced lung cancer. Based on 
promising phase II studies, dose escalation gave hope for 
better local control. However, the phase III RTOG 0617 [1] 
dose escalation trial showed that treatment related deaths 
can increase. Strict normal tissue constraints, as well as 
focus on the actual delivered dose, are essential when aiming 
for safe dose escalation. For standard doses, adaptive 
radiotherapy (ART) has mainly been concerned with ensuring 
target coverage, but with escalated doses anatomical 
changes during treatment can result in critical over dosage of 
organs at risk (OARs). Furthermore, it is important to monitor 
doses to known OARs such as the heart, and other structures 
as connective tissue and chest wall, where we don’t know 
the risk for high dose RT. The present study investigates the 
impact of anatomical changes during RT on the escalated 
dose distribution used in the Danish NARLAL2 dose escalation 
trial. 
 
Material and Methods: Fifteen patients (pts) with a standard 
treatment plan and an experimental dose escalation plan 
were analysed. The standard plan delivered a homogeneous 
dose of 66 Gy/ 33 fractions (fx) while the experimental plan 
delivered a heterogeneous escalated dose distribution. The 
dose escalation was driven by the most FDG-PET active region 
of the tumour and lymph nodes, with mean doses up to 95 
Gy/ 33 fx and 74Gy/ 33 fx, respectively. The dose 
distribution was limited by constraints to the OARs (Table 1). 
All pts had a surveillance scan (sCT) at fx 10 and ten pts also 
at fx 20. The original treatment plans were recalculated on 
the sCTs to evaluate the impact of inter-fractional changes 
during the RT course. For most OARs, a maximum dose 
constraint was set, allowing higher doses for < 1cm3 of the 
OAR. The number of pts with OARs reaching the maximum 
dose for the escalation plan, was determined. For some pts, 
the volume receiving doses above the maximum constraint, 
increased on the sCT. Volume increments ΔV > 1cm3 were 
made up. 
 
 
 
Results: At least one OAR reached maximum dose constraint 
on planning CT (pCT) for all pts. Of these, 9 pts showed doses 
to OARs increasing above maximum dose on sCT, see Table. 
Heart doses (V50Gy) increased more than 1cm3 (up to 19 
cm3) in eight pts and in one pt the oesophagus was over 
dosed on the sCT. For connective tissue and chest wall, the 
volume receiving > 74 Gy increased more than 1cm3 on the 
sCT in 7 and 5 pts, respectively. The anatomical changes 
leading to higher OAR doses were tumour shrinkage (5 pt), 
body contour changes (3 pt) and resolving atelectasis (1 
pt).The mean dose to the PET-GTVT was 92±3Gy. In six pts, 
the mean dose decreased more than 1% (up to 10%) on the 
sCT. 
 
 
Conclusion: Anatomical changes during RT may result in 
increased doses to OAR. Introduction of dose escalation 
therefore requires frequent evaluation of treatment plans 
and ART should be used in order to avoid over dosage of 
OARs. 
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Purpose or Objective: Effective treatment options are 
needed for locally advanced lung cancer. Increased 
treatment precision and decreased treatment volumes are 
mandatory for more aggressive radiotherapy. Adaptive 
radiotherapy (ART) was implemented to adjust the treatment 
plan to positional or volumetric changes of the tumour, and 
to normal tissue changes like atelectasis. Recently, ART was 
shown to improve local control without increasing radiation 
pneumonitis [1]. The present study investigates the 
dosimetric consequences of ART for 235 patients. 
 
Material and Methods: ART intervention rules were 
implemented for lung cancer patients treated with definitive 
chemo-radiotherapy, in concordance with smaller PTV 
margins and daily online soft-tissue matching. Intervention 
rules derived from geometrical criteria for normal tissue and 
tumour changes. Violation of these for three consecutive 
fractions triggered an evaluation. If the observed change was 
suspected to lead to an underdosage of tumour/lymph nodes 
or an overdosage of normal tissue, a CT rescan and a replan 
were made. The original plan was recalculated on the rescan 
to evaluate the consequence of replanning for patients 
receiving a plan adaptation in a cohort of 235 consecutive 
patients treated with ART. For the first 50 patients, in order 
to assess the efficacy of the intervention rules, two 
additional surveillance CT scans were acquired during the RT 
course and the treatment plans were recalculated on these 
scans. The change in lung dose due to the implementation of 
ART was found comparing the treatment plans of the first 50 
ART-patients with 50 pre-ART-patients. 
 
Results: Due to ART, the PTV decreased from 569 cm3 to 398 
cm3, and consequentially the mean lung dose decreased from 
14.1 Gy (SE 0.6) to 12.6 (SE 0.6) Gy. The criterion for the 
need of adaptation was a decrease in target coverage of 
CTV>1% or PTV>3%. The cohort of patients with two 
surveillance scans showed coverage above this in 94% of the 
cases not replanned. Sixty-one (26%) patients treated with 
ART had at least one replan. In total 77 adaptations were 
made. Fifty three adaptations corrected for a decrease in 
overall target coverage. Figure 1 shows the extent of 
decrease and designates the reason for replanning. In five 
patients with several separate targets under dosage of one of 
the targets were seen. One patient was replanned in order to 
avoid overdosage of spinal cord. Three patients were 
replanned due to changes in atelectasis making match 
evaluation impossible. In 15 patients, target shrinkage or less 
conformal dose distributions counterbalanced the geometric 
shifts that triggered adaptation. 
 
 
Conclusion: The implementation of soft-tissue match and 
ART secured high treatment precision and allowed safe 
margin reduction in terms of persistent target coverage. The 
reduced margins reduced the mean dose to the lung.  
[1] M Tvilum et al. Acta Oncol 2015, Acta Oncol. 2015 Jul 
24:1-8. 
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Purpose or Objective: In rectal cancer 15% of the patients 
show a pathological complete response (pCR) after neo-
adjuvant chemo-radiotherapy and these patients show better 
overall survival. To increase this pCR rate, in several studies 
a boost dose is given to the tumor. To safely deliver this 
boost, insight in the tumor position is needed. Currently, 
online imaging techniques provide no contrast of the tumor. 
However, since tumors are situated in the rectal wall, which 
is visible on online imaging like CBCT, the rectal wall position 
may be used as a surrogate for the tumor position. We 
therefore investigate the feasibility of tracking a part of the 
rectal wall close to the initial tumor as a motion surrogate 
for the tumor, to be used in online adaptive boost 
radiotherapy in rectal cancer. 
 
Material and Methods: We scanned 16 patients daily on a 
1.5T MRI scanner during a one-week short course of 
radiotherapy (5 times 5Gy). Rectum and tumor were 
delineated on the T2 weighted scan of each day. All scans 
were registered on bony anatomy, mimicking daily patient 
set-up. For both tumor and rectum separately, displacements 
from the first day to every other day were determined, by 
calculating per voxel the shortest distance to each 
delineation. 
To find out how proximate to the tumor we have to define 
our rectum motion surrogate, we selected that part of the 
rectum that lies within 1, 3, 5, 7 and 10 mm of the initial 
tumor (ProximateRectum). For each point on these 
ProximateRectums, we determined the nearest point of the 
tumor as corresponding point. Between all the corresponding 
points of ProximateRectum and tumor, the displacements to 
every day were correlated to each other. We also determined 
how much of the variance in tumor motion was explained by 
each ProximateRectum. These analysis were done for the 1, 
3, 5, 7 and 10 mm ProximateRectum separately. 
 
Results: Different motion patterns were found for tumor and 
ProximateRectums, especially when movement of the tumor 
is in cranial caudal direction, since no anatomical landmarks 
are available (see figure 1). We found correlations of ρ = 
0.66, 0.64, 0.55, 0.53 and 0.45 (all p≤ 0.001) for 
ProximateRectum of respectively 1, 3, 5, 7 and 10 mm. This 
